Cellectis S.A.

CLLS

Healthcare|Biotechnology|FR

$1.07

+0.04 (+3.88%)

Tangible Book / Share

$0.40

Cash / Share

$1.66

Next Earnings Report

Nov 13, 2026

EPS est. -$0.18 · Revenue est. $15.6M

Financing Filings (last 12 months)

No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (1)

Aug 2027

Est. completion

P1P2B-cell Non-Hodgkin Lymphoma (B-NHL)

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

NCT05607420n=80

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Dec 2024

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03190278

Recent Press Releases

Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026

Oct 27, 2026 · GlobeNewsWire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS

Oct 22, 2026 · PRNewsWire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS

Oct 20, 2026 · GlobeNewsWire

Securities Fraud Investigation Into Cellectis S.A. (CLLS) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Oct 15, 2026 · GlobeNewsWire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS

Oct 15, 2026 · PRNewsWire

Cellectis S.A. (CLLS) Shareholders Who Lost Money – Contact Law Offices of Howard G.

Oct 15, 2026 · GlobeNewsWire

Securities Fraud Investigation Into Cellectis S.A. (CLLS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R.

Oct 14, 2026 · GlobeNewsWire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS

Oct 13, 2026 · GlobeNewsWire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS

Oct 8, 2026 · PRNewsWire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. - CLLS

Oct 6, 2026 · GlobeNewsWire

SEC Filings (63)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

Filed	Form	What it is	Links
Oct 28, 2026	6-K	Foreign issuer report	Document Index
Sep 14, 2026	6-K	Foreign issuer report	Document Index
Sep 11, 2026	6-K	Foreign issuer report	Document Index
Sep 11, 2026	6-K/A	Foreign issuer report	Document Index
Sep 1, 2026	6-K	Foreign issuer report	Document Index
Aug 6, 2026	S-8	Employee stock plan	Document Index
Aug 6, 2026	6-K	Foreign issuer report	Document Index
Aug 6, 2026	6-K	Foreign issuer report	Document Index
Jul 30, 2026	6-K	Foreign issuer report	Document Index
Jun 26, 2026	6-K/A	Foreign issuer report	Document Index
Jun 25, 2026	6-K	Foreign issuer report	Document Index
Jun 25, 2026	6-K	Foreign issuer report	Document Index
Jun 11, 2026	6-K	Foreign issuer report	Document Index
Jun 9, 2026	6-K	Foreign issuer report	Document Index
May 21, 2026	6-K	Foreign issuer report	Document Index
May 20, 2026	6-K	Foreign issuer report	Document Index
May 12, 2026	6-K	Foreign issuer report	Document Index
May 11, 2026	6-K	Foreign issuer report	Document Index
May 11, 2026	6-K	Foreign issuer report	Document Index
May 4, 2026	6-K	Foreign issuer report	Document Index
Apr 27, 2026	6-K	Foreign issuer report	Document Index
Apr 13, 2026	6-K	Foreign issuer report	Document Index
Mar 20, 2026	20-F	Annual report (foreign)	Document Index
Mar 20, 2026	6-K	Foreign issuer report	Document Index
Mar 12, 2026	6-K	Foreign issuer report	Document Index
Jan 8, 2026	6-K	Foreign issuer report	Document Index
Dec 15, 2025	6-K	Foreign issuer report	Document Index
Dec 12, 2025	SC 13D/A	Activist / 5%+ stake	Document Index
Dec 8, 2025	6-K	Foreign issuer report	Document Index
Dec 5, 2025	6-K	Foreign issuer report	Document Index
Nov 19, 2025	6-K	Foreign issuer report	Document Index
Nov 7, 2025	6-K	Foreign issuer report	Document Index
Nov 3, 2025	6-K	Foreign issuer report	Document Index
Oct 31, 2025	6-K	Foreign issuer report	Document Index
Oct 17, 2025	6-K	Foreign issuer report	Document Index
Oct 16, 2025	6-K	Foreign issuer report	Document Index
Oct 14, 2025	6-K/A	Foreign issuer report	Document Index
Oct 7, 2025	6-K	Foreign issuer report	Document Index
Sep 12, 2025	S-8	Employee stock plan	Document Index
Aug 4, 2025	6-K	Foreign issuer report	Document Index